Home » Topics » BioWorld Science

BioWorld Science
RSS

Diphosphonate antiarthritic agent developed at Toray

Dec. 12, 1997

Hokuriku describes new calcium agonist derived from intracellular calcium antagonist

Dec. 12, 1997

Daiichi files for approval of ebselen

Dec. 12, 1997

Kyowa Hakko prepares new, water-soluble indole for osteoporosis

Dec. 12, 1997

Tokyo Tanabe moves new oxytocin antagonist to clinic

Dec. 12, 1997

Immune Response recommended to continue Remune phase III trial

Dec. 12, 1997

LXR discovers new apoptosis-related proteins and genes

Dec. 12, 1997

BTG: Six-month 1997 highlights

Dec. 12, 1997

Alfacell: Q1 1998 highlights

Dec. 12, 1997

New data on PDL's SMART M195 antibody reported

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...